This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Lupus Research Institute Accelerates Drive For The Cure: Calls For $1 Million Distinguished Innovator Award Submissions

NEW YORK, Feb. 6, 2013 /PRNewswire/ --  The Lupus Research Institute (LRI), the world's leading supporter of innovative research in lupus, invites notable scientists from around the world to submit proposals for $1 million Distinguished Innovator Awards. Selection will be based on originality and potential to uncover the fundamental causes of autoimmunity in lupus that can propel toward a cure.

Launched just a year ago as the first $1 million private sector lupus research grants, the Distinguished Innovator Award program is already funding two highly promising projects that address the root causes of this complex disease. These Distinguished Innovator Award recipients, Drs. Ann Marshak-Rothstein at University of Massachusetts Medical School and Greg Barton at University of California, Berkeley, are taking different but complementary perspectives as they zero in on the family of proteins called Toll-like receptors (TLRs) as key triggers of the body's autoimmune attack on itself that characterizes lupus.

"In its first year the Distinguished Innovator Award elicited a large number of creative and scientifically sound proposals to examine the fundamental causes of lupus," noted world-leading immunologist Dr. William Paul, LRI Scientific Advisory Board Chairman and member of the National Academy of Sciences. "Based on the number of exceptional submissions, we look forward to a robust response from the international scientific community as the Institute requests proposals for the 2013 Award. The LRI is a catalyst for transformative research progress, and these awards promise to further propel the discovery process."

"Our Distinguished Innovator Award program is taking lupus research to a very different level," commented Lupus Research Institute President Margaret Dowd. "Based on an explosive decade of technological advances and scientific discoveries, many of which were funded by the LRI, finding the fundamental causes of lupus and driving to a cure is now an attainable goal.  Our strategy of identifying and supporting only the most novel research is effectively delivering the innovation needed to drive to a cure."

Two Grant Programs at the LRI Speed up the Search for a Cure The Distinguished Innovator Award complements the LRI's well-established Novel Research Grant program, which has produced many of the decade's pivotal discoveries in lupus. On a larger scale, the new Award provides researchers greater resources to delve more deeply into the root causes of lupus. Together the two grant initiatives further the Institute's mission to promote scientific discovery as the world's leading private supporter of novel research in lupus.

About Lupus A complex autoimmune disease, lupus affects over 1.5-million Americans, primarily women.

About The Lupus Research Institute The Lupus Research Institute (LRI), the world's leading private supporter of innovative research, pioneers discovery and champions scientific creativity to find solutions to lupus.

SOURCE Lupus Research Institute

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $95.01 0.00%
FB $99.75 0.00%
GOOG $682.74 0.00%
TSLA $147.99 0.00%
YHOO $27.05 0.00%


Chart of I:DJI
DOW 16,027.05 -177.92 -1.10%
S&P 500 1,853.44 -26.61 -1.42%
NASDAQ 4,283.7530 -79.3910 -1.82%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs